Delivery Order SPE2DB25D3504-SPE2DB25FVUCT

Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,524.40 firm fixed-price delivery order is for 4,567,394,905 units of CINACALCET HCL 30 MG TABLET 30S. The contract has a ceiling value of $5,524.40 and a completion date of February 27, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,034.80 Firm Fixed Price Delivery Order is for the supply of 4,568,163,424 units of Cinacalcet HCl 30 mg tablets. The contract has an ultimate completion date of May 7, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,768.88 firm fixed-price delivery order is for the supply of CINACALCET HCL 30 MG TABLET UD 20S, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is a delivery order worth $1,161.90 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Cinacalcet HCL 30 mg tablets and has a completion date of February 3, 2025. The contract is not designated as a set-aside and is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,878.75, is a Firm Fixed Price Delivery Order for the supply of Cinacalcet HCl 30 mg tablets. The contract has a period of performance through July 3, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,522.07 firm fixed-price delivery order is for the supply of 4,560,425,714 units of the drug Cinacalcet HCl 30 mg tablets. The contract has an ultimate completion date of March 30, 2023 and was awarded on March 29, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,047.36 fixed-price contract is for the delivery of Cinacalcet HCl 30 mg tablets, with a period of performance running through October 17, 2024. The contract is not designated as a set-aside and represents an open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,774.92 firm fixed-price delivery order is for the supply of Cinacalcet HCl 30 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Candesartan Cilexetil 32 mg tablets. The contract has a ceiling value of $3,720.60 and is a firm fixed-price delivery order with a completion date of May 29, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Calquence 100 mg tablets. The contract has a ceiling value of $5,593.77 and a completion date of June 16, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVUCT
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CINACALCET HCL 30 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,201.58 and a completion date of April 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/4/25, 11:28 AM